Trivitron Healthcare and University of Tartu, Estonia have signed a five-year memorandum of understanding (MoU) for broad scientific cooperation and furthering of medical education between India and Estonia. The cooperation will mainly be in areas of mass spectrometry, microchips, sequencing, molecular diagnostics and bio-banking.
Dr G S K Velu, Founder and MD of Trivitron Healthcare said, “Trivitron is actively pursuing R&D in the new generation IVD techniques like next gen sequencing, micro array, mass spectrometry and molecular diagnostics. We found the scientists of University of Tartu had some clear insights in advancement of technologies in this area and hence we have formed an alliance to cooperate in R&D and commercialisation of products in this area. Apart from this, we have identified several areas of R&D collaboration and medical education collaboration with closer India/ Finland and Estonia joint initiatives to improve access and affordability for high end medical technology initiatives in selected areas of focus. We are sure this will lead to several break through innovations in the focus areas .”
“The University of Tartu’s competence and means for innovative research and development activities are the reasons which motivated the major Indian enterprise Trivitron Healthcare to cooperate with the University of Tartu,” said Erik Puura, Vice-Rector for Development of the University of Tartu.
“Our aim is to forge contacts between employees with similar interests to exchange the newest knowledge and develop solutions furthering people’s health,” commented Jane Luht, Head of Technology Transfer, University of Tartu. The partners will also explore the opportunities to give medical education to the University of Tartu in India, Dubai or Shanghai.
EH News Bureau
- Advertisement -
